Lansoprazole may trigger or exacerbate restless legs syndrome and periodic limb movement disorder in hemodialysis patients
A 76-year-old hemodialysis patient developed dopaminergic-refractory RLS/PLMD after starting lansoprazole 15 mg/day. Symptoms nearly completely resolved within 14 days of lansoprazole withdrawal, with RLS-6 score dropping from 28 to 4, and a Naranjo score of 5 indicating a probable adverse drug reaction.
Evidence Score
Study Evidence
Study 1. Lansoprazole as a possible trigger of restless legs syndrome with suspected periodic limb movement disorder in a hemodialysis patient: a case report.
observationalNakata H, Nishiwaki K ยท CEN case reports (2026)
Result:
Mechanism Graph
Limitations
- โ Single case report with no control group, limiting generalizability
- โ Confounding from prior discontinuation of methyldopa, which may have contributed partial improvement
Frequently Asked Questions
What is the Naranjo score and what does a score of 5 mean?โผ
The Naranjo scale assesses the probability of an adverse drug reaction. A score of 5 indicates a 'probable' adverse drug reaction.
Why might lansoprazole trigger RLS in hemodialysis patients?โผ
PPIs like lansoprazole can impair iron absorption, and iron deficiency is a known trigger for RLS. Hemodialysis patients are already at risk for iron deficiency.
How quickly did symptoms improve after stopping lansoprazole?โผ
Symptoms showed near-complete resolution within 14 days of lansoprazole withdrawal.
Is this effect specific to lansoprazole or all PPIs?โผ
This case specifically implicates lansoprazole, but the authors suggest clinicians should reassess PPI necessity in general for atypical or refractory RLS/PLMD.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Nakata H, Nishiwaki K. "Lansoprazole as a possible trigger of restless legs syndrome with suspected periodic limb movement disorder in a hemodialysis patient: a case report.." CEN case reports, 2026. PMID: 41999568 DOI: 10.1007/s13730-026-01099-1